Sun Pharmaceutical Complete Financial Statements

SUNPHARMA • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015

Complete Financial Data Export

Export complete financial statements for Sun Pharmaceutical (SUNPHARMA). Downloads include all available records across all periods. For market performance, see the SUNPHARMA stock price today .

Profitability Ratios

Net Profit Margin 21.01% 2025 data
EBITDA Margin 33.10% 2025 data
Operating Margin 31.00% 2025 data
Return on Assets 3.39% 2025 data
Return on Equity 4.31% 2025 data

Balance Sheet Ratios

Current Ratio 37.04 2025 data
Debt to Equity 1.27 2025 data
Equity Ratio 78.70% 2025 data
Asset Turnover 0.16 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
+9.2%
Year-over-Year
Net Profit Growth
+2.9%
Year-over-Year
EBITDA Growth
+15.4%
Year-over-Year
Expense Growth
+6.4%
Year-over-Year
Assets Growth
+7.7%
Year-over-Year
Equity Growth
+8.0%
Year-over-Year
Liabilities Growth
+7.7%
Year-over-Year
Operating Cash Flow Growth
+16.0%
Year-over-Year
Investing Cash Flow Growth
-579.3%
Year-over-Year
Financing Cash Flow Growth
-17.8%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Mar 2018 Jun 2018 Dec 2018 Sept 2017 Mar 2017 Jun 2017 Dec 2017 Sept 2016 Mar 2016 Jun 2016 Dec 2016 Sept 2015 Mar 2015 Jun 2015 Dec 2015
Revenue 14,875 13,429 14,251 13,618 12,419 13,057 13,903 12,297 11,099 11,990 12,407 10,894 9,500 10,646 11,274 9,780 8,575 9,822 10,247 9,019 8,180 7,640 9,124 8,150 7,326 8,472 8,159 7,198 7,014 7,339 7,850 6,845 7,050 6,319 6,727 7,869 7,622 8,164 7,805 6,973 6,493 6,691 7,260
Expenses 9,951 9,604 10,368 9,352 9,049 9,045 9,983 9,013 8,300 8,932 8,974 7,996 11,042 7,877 8,237 6,996 7,147 7,529 7,257 6,360 7,083 9,375 6,431 6,334 6,147 6,379 6,314 6,621 5,294 5,618 5,587 5,275 5,590 6,064 5,200 5,092 5,382 5,335 5,472 5,000 5,318 5,679 4,877
EBITDA 4,924 3,824 3,883 4,266 3,370 4,012 3,920 3,284 2,799 3,058 3,433 2,899 -1,542 2,769 3,037 2,784 1,427 2,293 2,990 2,659 1,098 -1,736 2,693 1,816 1,179 2,094 1,845 577 1,720 1,721 2,263 1,570 1,460 255 1,528 2,776 2,240 2,829 2,333 1,973 1,175 1,012 2,383
Operating Profit Margin % 31.00% 25.00% 25.00% 29.00% 23.00% 28.00% 26.00% 25.00% 23.00% 24.00% 26.00% 26.00% -18.00% 26.00% 26.00% 27.00% 16.00% 22.00% 26.00% 25.00% 12.00% -25.00% 27.00% 20.00% 13.00% 23.00% 21.00% 3.00% 21.00% 21.00% 27.00% 20.00% 18.00% 2.00% 21.00% 34.00% 27.00% 33.00% 29.00% 27.00% 13.00% 13.00% 31.00%
Depreciation 730 664 701 626 650 655 631 633 672 651 622 610 557 588 660 530 554 503 554 499 575 496 532 473 454 457 547 427 455 402 471 359 338 347 339 304 288 316 307 258 462 240 251
Interest 100 49 75 69 74 62 52 49 93 81 35 19 37 14 46 36 30 35 19 33 52 52 26 84 150 104 63 130 155 131 145 157 45 109 95 54 103 135 167 158 135 135 128
Profit Before Tax 4,168 3,254 3,173 3,598 2,816 3,424 3,476 2,791 2,240 2,481 3,000 2,412 -2,076 2,285 2,472 2,287 903 1,804 2,466 2,206 577 -2,184 2,163 1,433 694 1,647 1,351 112 1,376 1,274 1,730 1,114 1,389 -159 1,148 2,930 2,087 2,628 2,102 1,572 591 872 2,040
Tax 1,043 1,100 880 561 157 563 563 406 257 476 440 157 152 191 291 200 61 400 340 263 85 242 250 270 -26 151 332 272 -187 88 269 113 3 164 792 458 424 360 380 272 -596 115 100
Net Profit 3,125 2,154 2,293 3,037 2,659 2,861 2,913 2,385 1,983 2,006 2,561 2,256 -2,227 2,093 2,181 2,086 842 1,404 2,126 1,943 493 -2,426 1,913 1,163 721 1,497 1,019 -160 1,563 1,186 1,461 1,002 1,386 -323 356 2,471 1,663 2,268 1,722 1,299 1,186 757 1,940
Earnings Per Share (₹) 13.00 9.00 9.50 12.70 11.10 11.80 12.10 9.90 8.30 8.40 10.50 9.40 -9.50 8.60 9.00 8.50 3.70 6.00 8.60 7.56 1.67 -6.90 7.72 4.43 2.65 5.78 3.81 -1.12 5.60 4.41 5.18 3.80 5.20 -1.77 1.34 9.30 5.90 8.50 6.10 4.30 3.70 2.30 6.40

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 92,101 85,500 80,744 69,808 67,667 68,253 64,694 64,516 61,410 55,530 49,028
Current Assets 52,594 43,433 39,862 34,865 30,442 31,654 31,069 31,636 32,954 29,941 29,122
Fixed Assets 22,586 23,248 24,065 22,665 21,553 22,847 21,837 18,853 17,675 15,872 12,683
Capital Work in Progress 6,644 5,354 4,973 1,287 1,567 1,220 1,411 2,465 2,801 2,175 2,039
Investments 18,354 15,026 14,824 12,849 9,612 10,143 7,903 7,143 1,192 1,830 2,117
Other Assets 44,517 41,872 36,881 33,007 34,935 34,042 33,544 36,056 39,742 35,653 32,189
LIABILITIES
Total Liabilities 92,101 85,500 80,744 69,808 67,667 68,253 64,694 64,516 61,410 55,530 49,028
Current Liabilities 1,420 1,390 1,522 1,533 2,041 3,421 2,632 2,454 3,093 5,319 4,186
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 72,486 67,126 59,316 51,066 49,480 49,125 44,723 42,198 40,431 37,068 28,489
Share Capital 240 240 240 240 240 240 240 240 240 241 207
Reserves & Surplus 71,978 63,427 55,755 47,771 46,223 45,025 41,169 38,074 36,400 32,741 25,383

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 14,072 12,135 4,959 8,985 6,170 6,555 2,196 3,907 7,082 6,686 5,616
Investing Activities -5,183 -763 -7,220 -5,556 407 -2,225 -310 -3,104 -4,186 -3,949 -1,502
Financing Activities -7,906 -6,710 2,376 -5,194 -5,981 -5,715 -2,731 -1,539 -2,285 -1,889 -1,187
Net Cash Flow 983 4,662 116 -1,765 596 -1,386 -844 -736 611 848 2,927